"Our perspective is knowing
the list price through an advertisement just helps patients have better
conversations with their doctor — and we think pricing should be an important
part of the conversation with that doctor."
— AHIP spokesperson Kristine Grow talked the Trump
administration's direct-to-consumer advertising guidelines for drug
manufacturers with AIS's RADAR
on Drug Benefits. The new rules are set to take effect in April
2019.
No comments:
Post a Comment